Patterns of major depression and drug-related problems amongst heroin users across 36 months

Psychiatry Research

Volumn 166, Issue 1, 2009, Pages 7-14

  Darke, Shane ^a   Mills, Katherine ^a   Teesson, Maree ^a   Ross, Joanne ^a   Williamson, Anna ^a   Havard, Alys ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Longitudinal; Opioids; Psychopathology; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH; PRIORITY JOURNAL; SHORT FORM 12; STRUCTURED INTERVIEW; SUICIDE ATTEMPT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BUPRENORPHINE; COHORT STUDIES; COMORBIDITY; CRIME; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HEROIN; HEROIN DEPENDENCE; HUMANS; LONGITUDINAL STUDIES; MALE; METHADONE; MIDDLE AGED; NARCOTICS; NEEDLE SHARING; NEW SOUTH WALES; OVERDOSE; PROGNOSIS; SUBSTANCE ABUSE, INTRAVENOUS; SUICIDE, ATTEMPTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 60349106879     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2007.12.007     Document Type: Article

References (38)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed. Text Revision) (2000), APA, Washington, DC
2. Andrews G., Hall W., Teesson M., and Henderson S. The Mental Health of Australians: National Survey of Mental Health and Wellbeing (1999), Commonwealth Department of Health and Aged Care, Canberra
3. Ball J.C., and Ross A. The effectiveness of methadone treatment. Patients, Programs, Services, and Outcome (1991), Springer-Verlag, New York
4. Brienza R.S., Stein M.D., Chen M.H., Cogineni A., Sobota M., Maksad J., Hu P., and Clark J. Depression among needle exchange and methadone maintenance clients. Journal of Substance Abuse Treatment 18 (2000) 331-337
5. Brooner R.K., King V.L., Kidorf M., Schmidt C.W., and Bigelow G. Psychiatric and substance use morbidity among treatment-seeking opioid users. Archives of General Psychiatry 54 (1997) 71-80
6. Cacciola J.S., Alterman A.I., Rutherford M.J., McKay J.R., and Mulvaney F.D. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug and Alcohol Dependence 61 (2001) 271-280
7. Darke S. Self-report among injecting drug users: a review. Drug and Alcohol Dependence 51 (1998) 253-263
8. Darke S., and Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug and Alcohol Dependence 48 (1997) 135-141
9. Darke S., Hall W., Heather N., Wodak A., and Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opioid users: the opiate treatment index. British Journal of Addiction 87 (1992) 593-602
10. Darke S., Ross J., Lynskey M., and Teesson M. Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors. Drug and Alcohol Dependence 73 (2004) 1-10
11. Darke S., Ross J., Teesson M., Ali R., Cooke R., Ritter A., and Lynskey M. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment 28 (2005) 255-263
12. Darke S., Degenhardt L., and Mattick R. Mortality Amongst Illicit Drug Users: Epidemiology, Causes and Intervention (2007), Cambridge University Press, Cambridge
13. Darke S., Ross J., Mills K.L., Williamson A., Havard A., and Teesson M. Borderline personality disorder and persistently elevated levels of risk in 36 month outcomes. Addiction 102 (2007) 1140-1146
14. Dean A., Bell J., Christie M.J., and Mattick R.P. Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence. European Psychiatry 19 (2004) 510-513
15. Dinwiddie S.H., Reich T., and Cloninger C.R. Psychiatric comorbidity and suicidality among intravenous drug users. Journal of Clinical Psychiatry 53 (1992) 364-369
16. Dorus W., and Senay E.C. Depression, demographic dimensions and drug abuse. American Journal of Psychiatry 137 (1980) 699-704
17. Gossop M., Marsden J., Stewart D., and Treacy S. Change and stability of change after treatment of drug misuse. 2 year outcomes from the National Treatment Outcome Research Study (UK). Addictive Behaviors 27 (2002) 155-166
18. Harris C., and Barraclough B. Suicide as an outcome for mental disorders. British Journal of Psychiatry 170 (1997) 205-228
19. Havard A., Teesson M., Darke S., and Ross J. Depression among heroin users: 12 month outcomes from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment 30 (2006) 355-362
20. Hubbard R.L., Craddock S.G., Flynn P.M., Anderson J., and Etheridge R.M. Overview of one year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 11 (1997) 261-278
21. Jackson C.T., Covell N.H., Frisman L.K., and Essock S.M. Validity of self-reported drug use among people with co-occurring mental health and substance use disorders. Journal of Dual Diagnosis 1 (2004) 49-63
22. Joe G.W., Broome K.M., and Simpson D.D. Retention and patient engagement in models for different treatment modalities in DATOS. Drug and Alcohol Dependence 57 (1999) 113-125
23. Kosten T.R., Rounsaville B.J., and Kleber H.D. A 2.5 year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Archives of General Psychiatry 43 (1986) 733-738
24. Liang K.Y., and Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
25. Mills K.L., Lynskey M., Teesson M., Ross J., and Darke S. Post-traumatic stress disorder among people with heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and correlates. Drug and Alcohol Dependence 77 (2005) 243-249
26. Ross J., Teesson M., Darke S., Lynskey M., Ali R., Ritter A., and Cooke R. Short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addictive Disorders and Their Treatment 5 (2006) 133-144
27. Rossow I., and Lauritzen G. Shattered childhood: a key issue in suicidal behavior among drug addicts. Addiction 94 (2001) 209-219
28. Rounsaville B.J., Kosten T.R., Weissman M.M., and Kleber H.D. Prognostic significance of psychopathology in treated opiate addicts. Archives of General Psychiatry 43 (1986) 739-745
29. Simpson D.D., and Marsh K.L. Relapse and recovery among opioid addicts 12 years after treatment. In: Tims F.M., and Leukefeld C.G. (Eds). Relapse and Recovery in Drug Abuse. NIDA Research Monograph no. 72 (1986), Department of Health and Human Services, Rockville, MD.
30. SPSS inc. SPSS for Windows (2006), 14.0. SPSS Inc., Chicago
31. Strain E.C., Stitzer M.L., and Bigelow G.E. Early treatment time course of depressive symptoms in opiate addicts. Journal of Nervous and Mental Disease 179 (1991) 215-221
32. Teesson M., Havard A., Fairbairn S., Ross J., Lynskey M., and Darke S. Depression among entrants for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Drug and Alcohol Dependence 78 (2005) 309-315
33. Twisk J.W.R. Applied Longitudinal Data Analysis for Epidemiology (2003), Cambridge University Press, Cambridge
34. Ware J.E., Kosinski M., and Keller S.D. A 12-item short-form health survey: construction of scales, and preliminary tests of reliability and validity. Medical Care 34 (1996) 220-233
35. Welp E.A.E., Bosman I., Langedam M.W., Totte M., Maes R.A.A., and van Ameijden E.J.C. Amount of self-reported illicit drug use compared to quantitative hair test results in community-recruited young drug users in Amsterdam. Addiction 98 (2003) 987-994
36. Wilcox H.C., Conner K.R., and Caine E.D. Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies. Drug and Alcohol Dependence 76S (2004) S11-S19
37. Woody G.E., McLellan A.T., Luborsky L., and O'Brien C.P. Twelve-month follow-up of psychotherapy for opiate dependence. American Journal of Psychiatry 144 (1987) 590-596
38. World Health Organization. Composite International Diagnostic Interview (version 1.1) (1993), WHO, Geneva